Merck and Isomorphic Labs enter strategic research collaboration
MRK•Merck and Isomorphic Labs will collaborate on oncology small molecule candidates using Isomorphic Labs’ ISODDE drug design engine. Merck will handle development, manufacturing and commercialization, while Isomorphic Labs will receive an upfront payment, milestones and tiered royalties, and an option to co-fund development for elevated royalties.
1. Collaboration terms
Merck and Isomorphic Labs will collaborate on oncology small molecule candidates using Isomorphic Labs’ ISODDE drug design engine. Merck will handle development, manufacturing and commercialization of collaboration products. Isomorphic Labs will receive an upfront payment, milestones and tiered royalties, and has an option to co-fund development for elevated royalties.




